Myung In Pharmaceutical LTD. (KRX:317450)
South Korea
· Delayed Price · Currency is KRW 56,700
+500 (0.89%)
At close: Apr 29, 2026
KRX:317450 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 820,520 | 1,005,940 | - | - | - | - | Upgrade
|
| Enterprise Value | 312,214 | 532,289 | - | - | - | - | Upgrade
|
| Last Close Price | 56200.00 | 68900.00 | - | - | - | - | Upgrade
|
| PE Ratio | 8.37 | 12.35 | - | - | - | - | Upgrade
|
| PS Ratio | 2.86 | 3.50 | - | - | - | - | Upgrade
|
| PB Ratio | 1.03 | 1.27 | - | - | - | - | Upgrade
|
| P/TBV Ratio | 1.04 | 1.27 | - | - | - | - | Upgrade
|
| P/FCF Ratio | 15.93 | 19.52 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 10.06 | 12.33 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.09 | 1.85 | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 3.02 | 5.15 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 3.38 | 5.76 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 6.06 | 10.33 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.03 | 0.04 | 0.06 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.09 | 0.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.64 | -0.64 | -0.48 | -0.39 | -0.32 | -0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.91 | -4.91 | -2.45 | -1.93 | -1.58 | -1.34 | Upgrade
|
| Net Debt / FCF Ratio | -9.87 | -9.87 | -3.54 | -2.57 | -2.39 | -1.82 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.49 | 0.49 | 0.50 | 0.52 | Upgrade
|
| Inventory Turnover | 1.82 | 1.82 | 1.73 | 1.70 | 1.74 | 1.56 | Upgrade
|
| Quick Ratio | 12.52 | 12.52 | 7.28 | 6.37 | 5.76 | 4.52 | Upgrade
|
| Current Ratio | 13.93 | 13.93 | 8.65 | 7.85 | 7.15 | 5.71 | Upgrade
|
| Return on Equity (ROE) | 12.28% | 12.28% | 13.68% | 16.63% | 14.36% | 16.91% | Upgrade
|
| Return on Assets (ROA) | 8.12% | 8.12% | 10.51% | 10.52% | 10.53% | 11.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 25.26% | 26.33% | 25.70% | 23.54% | 19.48% | 21.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.60% | 11.60% | 17.30% | 17.30% | 17.40% | 19.00% | Upgrade
|
| Earnings Yield | 9.92% | 8.09% | - | - | - | - | Upgrade
|
| FCF Yield | 6.28% | 5.12% | - | - | - | - | Upgrade
|
| Payout Ratio | 13.75% | 13.75% | 8.15% | 30.06% | 19.50% | 23.43% | Upgrade
|
| Buyback Yield / Dilution | -8.23% | -8.23% | -0.01% | - | - | - | Upgrade
|
| Total Shareholder Return | -5.56% | -8.23% | -0.01% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.